Table 1.
Characteristics of the Study Cohort and the Group Lost to Follow-up
| Study Cohort (N = 402) |
Losses to Follow-up (n = 40) |
|||
|---|---|---|---|---|
| Variable | No. With Data | No. (%) | No. With Data | No. (%) |
| Age, ya | 402 | 27.5 (22.5–36.7) | 40 | 26.5 (21.2–36.1) |
| Female sex | 402 | 158 (39) | 40 | 12 (30) |
| Low BMI or malnutritionb | 348 | 100 (29) | 33 | 15 (46) |
| No. of prior tuberculosis regimensa | 402 | 3 (2–4) | 40 | 3 (2–4) |
| Received an aggressive regimen for ≥18 mo after sputum conversion | 402 | 243 (60.5) | 40 | 25 (62.5) |
| Bilateral chest cavitations | 389 | 195 (50) | 38 | 23 (61) |
| Alcohol or substance use | 367 | 55 (15) | 37 | 4 (11) |
| Ever smoked cigarettes | 367 | 40 (11) | 38 | 2 (5) |
| Diabetes mellitus | 360 | 9 (3) | 37 | 2 (5) |
| HIV infection | 397 | 3 (1) | 39 | 1 (3) |
| Psychiatric disorder | 373 | 58 (16) | 37 | 7 (19) |
| Resistant to ≥5 drugs | 402 | 277 (69) | 40 | 24 (60) |
| Received prior standardized MDR tuberculosis regimen | 402 | 176 (44) | 40 | 20 (50) |
| XDR tuberculosis | 402 | 26 (7) | 40 | 3 (8) |
Abbreviations: BMI, body mass index; HIV, human immunodeficiency virus; MDR, multidrug resistant; XDR, extensively drug resistant.
a Continuous variable; median (interquartile range) presented.
b Body mass index <18.5 in women or <20 in men, or a clinician diagnosis of malnutrition.